Similar Papers

Paper Title
Journal
Date
Author
The Role of GPR40 (FFAR1) in Pharmacological vs Physiological Control of Incretin Secretion
Yanyun Chen ... Chafiq Hamdouchi
The FASEB Journal | VOL. 31
Yanyun Chen, et. al.Yanyun Chen ... Chafiq Hamdouchi
01 Apr 2017
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function.
Mahesh Kumar Verma ... Baggavalli P Somesh
BMC Cell Biology | VOL. 15
Mahesh Kumar Verma, et. al.Mahesh Kumar Verma ... Baggavalli P Somesh
30 Jun 2014
GPR40: A therapeutic target for mediating insulin secretion
Xiao-Tao Feng ... Zhen Xie
International Journal of Molecular Medicine | VOL. 30
Xiao-Tao Feng, et. al.Xiao-Tao Feng ... Zhen Xie
26 Sep 2012
Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
Charles F Burant
Diabetes Care | VOL. 36
Charles F BurantCharles F Burant
17 Jul 2013
View more papers

More From: ACS Medicinal Chemistry Letters

Paper Title
Journal
Date
Author
Heterocyclic Assembly: An Underutilized Disconnection with Potential to Maximize High Fsp3 Chemical Space Exploration
Brandon M Taoka ... Rohan R Merchant
ACS Medicinal Chemistry Letters | VOL. -
Brandon M Taoka, et. al.Brandon M Taoka ... Rohan R Merchant
28 Jan 2025
Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors as Potential Treatment for Several Inflammatory and Neurodegenerative Diseases
Ahmed F Abdel-Magid
ACS Medicinal Chemistry Letters | VOL. -
Ahmed F Abdel-MagidAhmed F Abdel-Magid
27 Jan 2025
Discovery of Novel pH-Sensitive μ-Opioid Receptor Agonists as Potent Analgesics with Reduced Side Effects
Zhen Wang ... Yuan Wang
ACS Medicinal Chemistry Letters | VOL. -
Zhen Wang, et. al.Zhen Wang ... Yuan Wang
27 Jan 2025
Novel Pyrimidinyl Sulfonamide Derivatives as GPR17 Modulators
Taoqian Zhao ... Steven H Liang
ACS Medicinal Chemistry Letters | VOL. -
Taoqian Zhao, et. al.Taoqian Zhao ... Steven H Liang
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.